Medfinder
Back to blog

Updated: January 20, 2026

How to Help Your Patients Find Myrbetriq in Stock: A Provider's Guide

Author

Peter Daggett

Peter Daggett

Doctor helping patient find Myrbetriq at a pharmacy

A practical guide for urologists, PCPs, and NPs on directing patients who can't fill their Myrbetriq prescriptions — including resources, savings tools, and workflow tips.

When patients with overactive bladder call your office saying their Myrbetriq prescription can't be filled, having a ready playbook saves time for your staff and gets your patient back on therapy faster. This guide covers the most effective resources and talking points you can hand off directly to patients or use to troubleshoot access issues in-house.

Why Patients Are Having Trouble Filling Myrbetriq in 2026

Three distinct issues are creating access friction for Myrbetriq patients right now:

  1. Generic mirabegron supply disruption. A federal court ruling in April 2025 blocked Lupin and Zydus — two of the main generic manufacturers — from selling their mirabegron versions. Other generics (Alkem) remain available, but supply is inconsistent by pharmacy.
  2. Insurance step therapy. UnitedHealthcare (effective November 2025) now requires patients to fail two alternative OAB drugs before covering generic mirabegron. Other plans may have similar requirements.
  3. Brand cost barrier. Brand-name Myrbetriq costs $457+ per 30 tablets out of pocket. Even with insurance, Tier 3/4 copays can be prohibitive.

Resource 1: medfinder — For Pharmacy Stock Issues

When your patient simply cannot locate Myrbetriq at any local pharmacy, medfinder is an efficient solution to hand off. It is a paid service that calls local pharmacies on the patient's behalf to find which ones currently have the medication in stock, then texts the patient the results. Providers can direct patients to medfinder.com or recommend they call directly.

This is particularly useful given that Myrbetriq's availability varies by pharmacy based on which generic manufacturer they source from — a dynamic that even your staff can't easily look up.

Resource 2: Astellas Savings Programs — For Cost Issues

Astellas Pharma offers two patient support programs your office can recommend:

  • Momentum Savings Card: For commercially insured patients. Covers up to $70/month on Myrbetriq (maximum $840/year). Patients are responsible for the first $20 plus any amount over $90 per fill. Not valid for Medicare/Medicaid. Enroll at AstellasPharmaSupportSolutions.com or call 1-866-666-8244.
  • Patient Assistance Program (PAP): Provides brand Myrbetriq at no cost to eligible uninsured or underinsured patients who meet income criteria and have an FDA-approved indication. Call 1-800-477-6472 or visit AstellasPharmaSupportSolutions.com. Your office will need to complete paperwork with the patient.

Resource 3: Third-Party Coupons — GoodRx and SingleCare

For patients paying cash or whose insurance is not accepted at certain pharmacies, GoodRx and SingleCare discount coupons can dramatically reduce the cost of generic mirabegron. GoodRx shows prices as low as $117.62 for a 30-day supply at some pharmacies (73% off the average retail price of $441). SingleCare lists generic mirabegron for around $189 at participating pharmacies. These coupons cannot be used simultaneously with insurance but are often more affordable for patients on high-deductible plans.

Prescribing Practices That Reduce Access Friction

Small prescribing adjustments can prevent access issues before they start:

  • Allow generic substitution (DAW 0). Writing "mirabegron ER" or allowing substitution ensures pharmacies can dispense whichever form is in stock.
  • Recommend mail-order for maintenance therapy. Insurance mail-order programs (CVS Caremark, Express Scripts, OptumRx) maintain more consistent inventory for ongoing medications like Myrbetriq.
  • Document step therapy exceptions proactively. For patients where antimuscarinics are contraindicated (glaucoma, dementia risk, BOO), document this clearly before the insurer requests it.
  • Write 90-day supplies when appropriate. For stable, well-controlled patients, 90-day fills via mail-order reduce the frequency of potential supply disruptions.

Patient Handout Language You Can Use

Share this with patients whose Myrbetriq fill is denied or unavailable:

"If your pharmacy is out of Myrbetriq or can't fill your prescription today:

  1. Ask the pharmacist to check if they can order it (1-2 business days).
  2. Ask about BOTH brand Myrbetriq and generic mirabegron — they may have one but not the other.
  3. Use medfinder (medfinder.com) — they'll call local pharmacies for you and text you which ones have it.
  4. Check your out-of-pocket cost with a GoodRx coupon at GoodRx.com — it may be less than your copay."

When to Consider Switching Therapies

If access problems are persistent and the patient's OAB is disrupting quality of life, a short-term bridge with an available generic antimuscarinic (oxybutynin, tolterodine, solifenacin) may be appropriate while the Myrbetriq supply issue resolves. See our full clinical update: Myrbetriq Shortage: What Providers Need to Know in 2026.

Frequently Asked Questions

Tell patients to: (1) ask the pharmacist to special order it within 1-2 business days; (2) ask about both brand Myrbetriq AND generic mirabegron; (3) use medfinder (medfinder.com) to locate which nearby pharmacies have it in stock; and (4) check GoodRx or SingleCare for cash-price coupons that may be cheaper than their copay. If access issues persist, discuss a temporary bridge medication.

Document clearly in the patient's chart the clinical rationale for bypassing anticholinergic step therapy: contraindications (narrow-angle glaucoma, urinary retention history), prior documented failure or intolerance of anticholinergic OAB medications, cognitive impairment risk in elderly patients, or other clinically relevant factors. Submit a prior authorization with this documentation.

Yes, enrollment typically requires prescriber documentation and office staff coordination. The patient must meet income eligibility criteria and have a valid prescription. Staff can initiate the process by calling 1-800-477-6472 or visiting AstellasPharmaSupportSolutions.com. The program provides Myrbetriq at no cost for eligible patients with an FDA-approved indication who are uninsured or underinsured.

Yes. Vibegron (Gemtesa) is a beta-3 adrenergic agonist like mirabegron — the most pharmacologically similar alternative. It is taken as one 75 mg tablet daily. Clinical studies show comparable efficacy to mirabegron for OAB symptoms. The main drawback is that Gemtesa is brand-name only and similarly priced to Myrbetriq, though it may have different insurance coverage on your patient's plan.

Yes. medfinder is a paid service that calls pharmacies near the patient's location to check current stock of a specified medication, then texts results to the patient. It is appropriate for patients who are having difficulty locating Myrbetriq or any other medication at local pharmacies. Providers can direct patients to medfinder.com or to the medfinder provider portal at medfinder.com/providers.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Myrbetriq also looked for:

34,034 have already found their meds with Medfinder.

Start your search today.

34K+
5-star ratingTrusted by 34,034 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?